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Class II Histone Deacetylases Act as Signal-
Responsive Repressors of Cardiac Hypertrophy
naling pathways all result in the hypertrophic phenotype,
and whether this reflects the convergence of these path-
ways on a common downstream target or crosstalk be-
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Histone acetyltransferases (HATs) and histone de-University of Texas Southwestern Medical Center
6000 Harry Hines Boulevard acetylases (HDACs) govern gene expression patterns
by being recruited to target genes through associationDallas, Texas 75390
2 Cardiovascular Division with specific transcription factors (Jenuwein and Allis,
2001). HATs promote gene activation by acetylatingUniversity of Iowa College of Medicine and Iowa
City Veterans Affairs Medical Center nucleosomal histones, thereby relaxing chromatin struc-
ture. HAT activity is opposed by HDACs, which deacet-Iowa City, Iowa 52242
ylate histones, resulting in chromatin condensation and
transcriptional repression (Johnson and Turner, 1999).
Vertebrate HDACs are categorized into three classesSummary
(Grozinger and Schreiber, 2002). Class I includes HDACs
1, 2, 3, and 8, which are expressed ubiquitously. ClassThe heart responds to stress signals by hypertrophic
II HDACs (4, 5, 7, and 9) are highly expressed in striatedgrowth, which is accompanied by activation of the
muscles and brain and contain N-terminal extensionsMEF2 transcription factor and reprogramming of car-
that interact with positive and negative transcriptionaldiac gene expression. We show here that class II his-
cofactors. The N-terminal regions of class II HDACs alsotone deacetylases (HDACs), which repress MEF2 ac-
contain two conserved CaMK phosphorylation sitestivity, are substrates for a stress-responsive kinase
(McKinsey et al., 2000a, 2002). Phosphorylation of thesespecific for conserved serines that regulate MEF2-
sites leads to the binding of 14-3-3 proteins, which in-HDAC interactions. Signal-resistant HDAC mutants
duces HDAC nuclear export and results in derepressionlacking these phosphorylation sites are refractory to
of HDAC target genes (McKinsey et al., 2000b; Grozingerhypertrophic signaling and inhibit cardiomyocyte hy-
and Schreiber, 2000).pertrophy. Conversely, mutant mice lacking the class II
Among the targets of class II HDACs is myocyte en-HDAC, HDAC9, are sensitized to hypertrophic signals
hancer factor-2 (MEF2), a MADS-box transcription fac-and exhibit stress-dependent cardiomegaly. Thus,
tor highly expressed in myocytes (Black and Olson,class II HDACs act as signal-responsive suppressors
1998). Association of class II HDACs with MEF2 resultsof the transcriptional program governing cardiac hy-
in repression of MEF2 activity (McKinsey et al., 2002).pertrophy and heart failure.
This repressive influence can be relieved by CaMK-
dependent phosphorylation of HDACs, which inducesIntroduction
their dissociation from MEF2 (McKinsey et al., 2000a,
2000b; Lu et al., 2000a, Zhang et al., 2001b). MEF2-The adult myocardium responds to stress by hypertro-
interacting transcriptional repressor (MITR) is a predom-phic growth, which is accompanied by an increase in
inant splice variant of HDAC9 expressed in the heartsize of cardiac myocytes, assembly of sarcomeres, and
(Sparrow et al., 1999; Zhou et al., 2001). MITR associatesactivation of a fetal cardiac gene program (Chien, 1999).
with MEF2 in a signal-responsive manner (Zhang et al.,Induction of fetal cardiac genes results in altered con-
2001b), but lacks a catalytic domain. Nevertheless, MITRtractility and calcium handling and correlates with im-
efficiently suppresses MEF2 activity by recruiting otherpaired cardiac function (Lowes et al., 2002). A variety
corepressors (Sparrow et al., 1999; Zhang et al., 2001a).of pathologic stimuli, including myocardial infarction,
Here, we show that diverse hypertrophic signals inhypertension, contractile abnormalities, and pressure
vivo lead to the activation of a cardiac HDAC kinaseoverload elicit the hypertrophic response. Autocrine and
that phosphorylates the signal-responsive sites in classparacrine signaling pathways involving angiotensin II
II HDACs and MITR. Mutant proteins lacking these phos-(ANGII), endothelin-1 (ET-1), and activators of the adren-
phorylation sites act as signal-resistant repressors ofergic system also contribute to myocyte hypertrophy.
cardiomyocyte hypertrophy and fetal cardiac gene ex-Several calcium-dependent signaling molecules, in-
pression in vitro. Conversely, HDAC9 knockout mice arecluding the calcium/calmodulin-dependent phospha-
super-sensitive to hypertrophic stimuli and spontane-tase calcineurin, calcium/calmodulin-dependent protein
ously develop cardiac hypertrophy with advanced age.kinase (CaMK), and mitogen-activated protein kinases
These findings demonstrate that class II HDACs act as(MAPKs) have been implicated in the transduction of
signal-responsive repressors of cardiac hypertrophy.hypertrophic stimuli (Frey et al., 2000). However, rela-
tively little is known of the terminal steps in these path-
ways that reprogram cardiac gene expression in the Results
nucleus. It is also unclear how different intracellular sig-
Activation of a Cardiac HDAC Kinase
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ster, Colorado, 80021. with two conserved CaMK phosphorylation sites flank-
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Figure 1. Elevated HDAC Kinase Activity in Hypertrophic Hearts
(A) Schematic diagram of class II HDACs. Class II HDACs have a bipartite structure, with a C-terminal catalytic (HDAC) domain and an
N-terminal extension with a MEF2 binding domain. Conserved phosphorylation sites flank the nuclear localization sequence (NLS) and a
nuclear export sequence (NES) is near the C terminus. MITR is a splice variant of HDAC9 that lacks an HDAC domain.
(B) Amino acid homologies surrounding the regulatory serines (arrowheads) in the class II HDACs.
(C) Schematic diagram of HDAC kinase assay. Kinase assays were performed with GST-HDAC substrates. The region of each HDAC that was
used as substrate is underlined in (A). A kinase from heart lysates phosphorylates the wild-type (WT) substrates, but not mutant (Mut) substrates
containing alanine in place of the regulatory serine residue.
(D and E) HDAC kinase assays were performed with heart extracts from thoracic aorta-banded (TAB) or sham-operated mice (D) or from wild-
type (wt) or MHC-calcineurin transgenic (Cn-Tg) mice. Values represent the average of at least three independent assays.
(F) HDAC kinase assays were performed with heart extracts derived from wild-type (lane 1) and Cn-Tg (lanes 2–23) mice in the absence (lanes
1 and 2) or presence (lanes 3–23) of diverse inhibitors (upper image). Kinase activity relative to that in extracts from Cn-Tg mice (lane 2) was
determined (lower image). Inhibitors were added to reactions at concentrations 20 times the IC50. Combo1 contained AIP and Go6983 and
combo2 contained HA1004 and Go6983. Inhibitor experiments were performed at least three times with comparable results. A representative
experiment is shown. For (D–F), enzyme activity was quantified as described in Experimental Procedures.
ing a nuclear localization sequence (NLS) near their N GST-HDAC5 substrates, respectively (P  0.05; Figure
1D). Hypertrophic hearts from transgenic mice express-termini (Figures 1A and 1B). To determine whether a
kinase specific for these phosphorylation sites might be ing activated calcineurin (Molkentin et al., 1998) also
showed pronounced elevation of HDAC kinase activityactivated in the heart in response to hypertrophic stimuli,
we developed an in vitro kinase assay using portions of (Figure 1E). Cardiac hypertrophy due to expression of
activated forms of CaMK and the MAP kinase MEK5 inHDAC4, HDAC5, and HDAC9/MITR encompassing the
conserved CaMK sites fused to GST as substrates (Fig- the heart also resulted in stimulation of HDAC kinase
activity (data not shown).ure 1C). Phosphorylation of GST-HDAC proteins was
readily detected in this assay (Figure 1C, WT). GST- To further characterize the HDAC kinase, we tested
its sensitivity to a panel of inhibitors (Figure 1F andHDAC fusion proteins in which the CaMK sites (Ser-246
in HDAC4, Ser-259 in HDAC5, and Ser-218 in HDAC9/ data not shown). The HDAC kinase was inhibited by
staurosporin and K252a, which are general serine/threo-MITR) were mutated to alanines (Figure 1C, Mut) were
not phosphorylated by cardiac extracts, demonstrating nine kinase inhibitors. The kinase was also partially in-
hibited by HA1004, which is a broad inhibitor known tothat the kinase activity is specific for the CaMK sites.
Constriction of the thoracic aorta in mice creates a inhibit CaMK, PKA, and PKG. However, the kinase was
not inhibited by compounds that inhibit CaMK (KN62,pressure gradient in excess of 50 mm Hg and results in
approximately a 50% increase in cardiac mass within KN93, or AIP), PKA (H-89 or 4-cyano-3-methylisoquino-
line), PKC (GF109203X, Go¨6976, Go¨6983, or Ro-31-8425),21 days (Hill et al., 2000). Analysis of cardiac extracts
from sham-operated and thoracic aorta-banded (TAB) MEK (PD98059), p38 (SB203580), cdk (olomoucine and
roscovitine), or PI-3-kinase (rapamycin and wortman-mice showed that pressure overload increased HDAC
kinase activity 2.1- and 1.7-fold, using GST-HDAC9 and nin). The kinase was also not inhibited by inhibitors of
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Figure 2. Inhibition of Fetal Gene Expression
and Acetylation by Signal-Resistant MITR
(A) Neonatal rat cardiomyocytes were in-
fected with adenoviruses encoding phos-
phorylation site mutants of HDAC5 (Ad-
HDAC5 S259/498A) or MITR (Ad-MITR S218/
448A) and were then stimulated with PE for 24
hr. Transcripts for ANF, -MHC, and GAPDH
were detected by dot blot. ANF and -MHC
expression are shown relative to that in un-
treated, uninfected controls and normalized
to the level of GAPDH.
(B) Cardiomyocytes were infected with aden-
oviruses encoding Myc-tagged MITR or MITR
S218/448A at the indicated multiplicity of in-
fection (moi). Cells maintained in serum-free
medium were stimulated with PE for 24 hr.
The relative levels of -MHC mRNA in Ad-
MITR versus Ad-MITR S218/448A-infected
cells were quantified by dot blot and normal-
ized to the level of GAPDH.
(C) The expression of ectopic MITR in cardio-
myocyte lysates was determined by Western
blotting with an anti-Myc antibody (upper im-
age). The blot was reprobed with an anti-
-tubulin antibody to reveal total protein input
(bottom image).
(D) Soluble chromatin was prepared from
cardiomyocytes infected with either Ad-GFP
or Ad-MITR S218/448A and treated for 24 hr
with FBS or PE. Chromatin was immunopre-
cipitated with an antibody specific for acet-
ylated histone H3 and precipitated genomic
DNA was analyzed by PCR using primers for
ANF, -MHC, GAPDH, and -cardiac actin
promoters. Positions of primers (numbers)
and the GATA sites (black boxes) relative to
the transcription initiation sites of each gene
are shown. The lower image shows a DNA
input control in which PCR amplification was
performed prior to immunoprecipitation.
PKG, Raf, or MLCK (data not shown). Combinations of to-alanine mutations at positions 259/498 and 218/448,
respectively, abrogated the induction of these genes.the above inhibitors also failed to inhibit the kinase.
Paradoxically, inhibitor combinations that contained The HDAC5 and MITR mutant proteins had no effect on
expression of glyceraldehyde-3-phosphate dehydrogen-HA1004 were less effective than HA1004 alone. We sus-
pect this is due to counteracting effects of one inhibitor ase (GAPDH). Because MITR was effective in repressing
fetal gene expression and is the predominant form ofon the action of another.
These results demonstrate that diverse hypertrophic HDAC9 expressed in the heart, we used it in subsequent
studies of the mechanisms involved in the blockade tocues stimulate the activity of a kinase (or kinases) spe-
cific for the phosphorylation sites that inactivate class hypertrophic signaling.
If the regulatory phosphorylation sites in MITR andII HDACs and suggest that the kinase measured in this
assay does not correspond to kinases previously impli- class II HDACs are targets for hypertrophic stimuli, then
wild-type HDAC proteins would be expected to be lesscated in hypertrophic signaling.
effective inhibitors of hypertrophy than mutant proteins
lacking these sites. To test this possibility, we comparedSignal-Resistant HDACs Inhibit Hypertrophy
and Acetylation of Fetal Cardiac Genes the effects of wild-type MITR and the MITR S218/448A
mutant on expression of -MHC in cardiomyocytesIn light of the finding that cardiac hypertrophy was asso-
ciated with enhanced HDAC kinase activity, which would treated with PE. As shown in Figure 2B, at comparable
multiplicities of infection (moi’s), Ad-MITR S218/448Abe predicted to inactivate HDACs and MITR, we tested
whether mutant proteins lacking the regulatory phos- was more than twice as effective in suppressing -MHC
expression than wild-type MITR. The activity of Ad-MITRphorylation sites were able to prevent hypertrophic gene
expression in primary rat cardiomyocytes. As shown in S218/448A in this assay is an underestimate of its rela-
tive potency because the mutant protein accumulatesFigure 2A, the hypertrophic marker genes atrial natri-
uretic factor (ANF) and -myosin heavy chain (-MHC) to a level about 10-fold lower than the wild-type protein
at the same moi (Figure 2C).are upregulated in cardiomyocytes stimulated with the
adrenergic agonist phenylephrine (PE), a potent inducer To determine whether signal-resistant MITR changed
the acetylation state of histones associated with fetalof hypertrophy. Infection of cardiomyocytes with adeno-
viruses that expressed HDAC5 and MITR with serine- cardiac genes, we performed chromatin immunoprecipi-
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Figure 3. Prevention of Hypertrophy by MITR
(A and B) Cardiomyocytes were cultured ei-
ther in the absence of virus or were infected
with adenoviruses encoding GFP or Myc-
tagged MITR S218/448A. After stimulation
with PE or FBS for 24 hr, cells were fixed
and stained with antibody against sarcomeric
-actinin (A, red signal) or ANF (B, perinuclear
red signal). Adenovirus-infected cells were
identified by GFP fluorescence or costaining
with anti-Myc antibody to reveal ectopic
MITR (green signal). Scale bar equals 20 m.
(C) Cardiomyocytes were cultured and in-
fected with adenoviruses as described
above. Cells maintained in serum-free me-
dium were stimulated with FBS, PE, ET-1,
ANGII, or IGF-1. After 24 hr, RNA was isolated
and the indicated transcripts were measured
by dot blot. Numbers indicate the expression
level of each transcript in the presence of
Ad-MITR S218/448A relative to Ad-GFP and
normalized to GAPDH.
tation (ChIP) assays with an antibody specific for acet- tion in the presence of Ad-MITR S218/448A. Thus, there
was a direct correlation between histone deacetylationylated histone H3. Associated genomic DNA was then
analyzed by PCR using primers specific for the promoter and repression of fetal gene expression by signal-resis-
tant MITR, suggesting that MITR repressed fetal genesregions of the ANF and -MHC genes. As a control,
cardiomyocytes were infected with an adenovirus en- by reducing the acetylation state of their promoters.
Neonatal cardiomyocytes assemble organized sar-coding green fluorescent protein (GFP). As shown in
Figure 2D, the promoter regions of ANF or -MHC are comeres in the presence of hypertrophic agonists.
Cardiomyocytes expressing the phosphorylation sitehighly acetylated in cardiomyocytes infected with Ad-
GFP and treated with either fetal bovine serum (FBS) mutant of MITR were unable to reorganize sarcomeres
or upregulate expression of ANF protein in response toor PE. In contrast, infection with Ad-MITR S218/448A
significantly reduced acetylation of these promoters in stimulation by PE or FBS (Figures 3A and 3B). Identical
results were obtained with adenovirus encoding thethe presence of hypertrophic stimuli. The GAPDH and
-cardiac actin genes, which are not regulated during HDAC5 S259/498A mutant (data not shown). Similarly,
Ad-MITR S218/448A prevented induction of -MHC andhypertrophy, did not show a change in histone acetyla-
Inhibition of Cardiac Hypertrophy by HDACs
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Figure 4. Targeting of Mouse HDAC9
(A and B) A diagram of the HDAC9 and MITR proteins is shown above the mouse HDAC9 locus. Sizes of introns in kilobases (kb) and exons
(filled boxes) are indicated. In the targeting vector, a nuclear LacZ (nLacZ) reporter was inserted in-frame with exon 4. Homologous recombination
resulted in deletion of exons 4 and 5, which encode the MEF2 binding domain of HDAC9/MITR. Insertion of the nLacZ gene introduced a
BamHI site that was used in conjunction with the indicated external 5 probe to distinguish the wild-type (6.5 kb) and mutant (4.1 kb) alleles
by Southern blot (B).
(C) Genomic DNA from mice of the indicated genotypes was analyzed by PCR using primers specific for the 5 and 3 regions of the targeted
mutation.
(D) The positions of the primers within HDAC9 exons are shown (lower image). Targeting the HDAC9 locus results in an aberrant mRNA
splicing event between exons 3 and 6, as evidenced by the 300 base pair (bp) PCR product using primers P1 and P3, which is not present
in wild-type controls. Sequencing of this RT-PCR product revealed a frameshift that introduced stop codons that prevent translation of
sequences downstream of exon 3. L7 transcripts were amplified as a control for cDNA integrity.
(E) The consequences of HDAC9 gene disruption on the expression of mRNA transcripts for HDACs 1–8 were assessed by semi-quantitative
RT-PCR using heart RNA from mice of the indicated HDAC9 genotypes.
ANF in response to FBS, ET-1, ANGII, and insulin-like HDAC9 because among the class II HDACs, it is ex-
pressed at the highest levels in the heart and becausegrowth factor-1 (IGF-1; Figure 3C). These findings sug-
gested that phosphorylation of the regulatory serines MITR, the primary product of the HDAC9 locus, was
highly effective in suppressing hypertrophy in vitro.in MITR and HDAC5 was necessary for hypertrophy in
response to diverse agonists. The targeted mutation deleted most of exon 4 and all
of exon 5, which encode residues 99–176 that encom-
pass the MEF2 binding domain of the protein (FiguresGeneration of HDAC9 Mutant Mice
To further investigate the potential involvement of class 4A–4C). HDAC9 mutant mice were obtained at predicted
Mendelian ratios and showed no discernible pathologi-II HDACs as suppressors of cardiac hypertrophy in vivo,
we inactivated the mouse HDAC9/MITR gene by homol- cal or histological abnormalities at early age (data not
shown).ogous recombination in ES cells and generated HDAC9
mutant mice (Figures 4A–4C). We chose to focus on To confirm that the mutation created a null allele, we
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performed RT-PCR analysis using primers representing
exon sequences within and surrounding the targeted
deletion region (Figure 4D). Using primer P2 (from de-
leted exon 4) and P3 (from exon 6), we detected a PCR
product in RNA from hearts of wild-type and HDAC9/
mice, but not of HDAC9 / mice. In contrast, using
primer P1 (from exon 3) and primer P3, RT-PCR products
were detected in RNA samples from mice of all geno-
types. In HDAC9/ mice, products of 549 and 300 bp,
corresponding to the wild-type and mutant transcripts,
respectively, were detected, whereas in HDAC9 / mice,
only the mutant transcript was detected (Figure 4D).
These results suggest that replacement of exon 4 and
exon 5 of HDAC9 with LacZ-Neo induced alternative
splicing of the targeted allele, such that exon 3 was
spliced to exon 6. This was confirmed by sequence
analysis of RT-PCR products. Such splicing caused a
frameshift and introduced two stop-codons immediately
following exon 3 (data not shown). Thus, no functional
HDAC9 or MITR protein is produced in homozygous
mutants. Furthermore, due to such alternative splicing,
the lacZ gene was not expressed in mutant mice (data
not shown).
To determine whether other HDACs might be upregu-
lated in mutant mice to compensate for the lack of
HDAC9, we compared the expression of HDACs 1–8
in hearts from wild-type and mutant mice by RT-PCR.
Transcripts encoding these other HDACs were ex-
pressed at normal levels in mutant hearts (Figure 4E).
HDAC9 Mutant Mice Develop Age-Dependent
Cardiac Hypertrophy and Are Hypersensitive
to Pressure Overload
Although HDAC9 mutant mice were initially normal, by
eight months of age they developed cardiac hypertrophy
and showed an average increase of 46% in heart weight/
body weight ratios compared to age-matched wild-type
controls (P  0.001; Figures 5A and 5B). In contrast, at
one month of age, there was no significant difference
in cardiac mass between wild-type and HDAC9/ mice.
Despite the lack of an overt phenotype in young
HDAC9/ mice, we wondered whether they might be
sensitized to hypertrophic stimuli, as would be predicted
if HDAC9 was a suppressor of stress-induced signaling
pathways. Since our earlier finding indicated that pres-
sure overload stimulated a kinase that would inactivate
class II HDACs, we compared the responses of wild-
Figure 5. Cardiac Hypertrophy in HDAC9 Mutant Micetype and HDAC9 mutant mice to thoracic aortic banding.
Banding of the thoracic aorta of wild-type mice resulted (A and B) HDAC9 mutant mice and wild-type littermates were sacri-
ficed at one and eight months of age and heart weight-to-bodyin an average increase in left ventricular (LV) mass of
weight ratios were determined. Values represent the mean  stan-56% after 21 days (Figure 5C). In contrast, hearts from
dard deviation (SD). N 	 5. Scale bar equals 2 mm.banded HDAC9/ mice showed a 105% increase in LV
(C) Hypersensitivity to TAB. Six-to-eight-week-old mice were sub-
mass over this period (P 0.01). These findings suggest jected to thoracic aortic banding (TAB) or to sham operation.
that HDAC9 acts as a suppressor of the signaling mech- Twenty-one days later, animals were sacrificed and the ratios of
left ventricular (LV) mass-to-body weight were determined. At leastanism that conveys a pressure stimulus to hypertrophic
five mice of each genotype were analyzed. Values represent thegrowth of the heart.
mean  SD.
HDAC9 Mutant Mice Are Sensitized to the
Hypertrophic Effects of Activated Calcineurin bearing the -MHC-calcineurin transgene (Cn-Tg). In-
deed, hearts from HDAC9 mutants showed an exagger-To further investigate the potential role of HDAC9 as a
suppressor of hypertrophy, we asked whether HDAC9/ ated response to activated calcineurin (Figures 6A and
6B). Whereas activated calcineurin resulted in a 130%mice were hypersensitive to calcineurin signaling. To
address this issue, we crossed HDAC9/ mice with mice increase in cardiac mass by 4 weeks of age, the HDAC9
Inhibition of Cardiac Hypertrophy by HDACs
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Figure 6. HDAC9 Mutant Mice Are Hypersen-
sitive to Calcineurin-Mediated Hypertrophy
(A) HDAC9 mutant mice were bred with mice
harboring the MHC-calcineurin transgene
(Cn-Tg). Hearts from one-month-old mice of
the indicated genotype were isolated (top im-
ages), sectioned, and stained with H and E
(middle and bottom images). The bottom im-
age shows high magnification images of H
and E-stained cardiomyocytes from the ven-
tricular septum. Scale bar equals 2 mm for
top and middle, 20 m for bottom.
(B) Heart weight-to-body weight ratios of
mice of the indicated genotypes were deter-
mined at four weeks of age. At least ten mice
of each genotype were analyzed. Values rep-
resent the mean  standard deviation.
(C) Total RNA was isolated from hearts of
mice of the indicated genotype and expres-
sion of transcripts for ANF, brain natriuretic
peptide (BNP), -MHC, and GAPDH was de-
termined by Northern blot analysis. The rela-
tive abundance of transcripts was quantified
and normalized to GAPDH.
(D) Wild-type or HDAC9 mutant mice were
crossed to transgenic mice harboring a
MEF2-dependent LacZ reporter gene. Off-
spring were bred with Cn-Tg mice. At least
two littermates of each genotype were sacri-
ficed at 8 weeks of age and cardiac MEF2
activity was detected by staining for -galac-
tosidase activity. Scale bar equals 2 mm.
mutants showed a 220% increase in response to cal- which harbors a LacZ transgene controlled by three
tandem copies of the MEF2 consensus binding site, tocineurin (P  0.001; Figure 6B). Massive hypertrophy
was observed in the right and left ventricular walls and determine whether HDAC9 regulated the respon-
siveness of MEF2 to calcineurin signaling in the intactinterventricular septum. Histological analysis demon-
strated that the increase in cardiac mass was a reflection heart in vivo. This MEF2-LacZ transgene provides a
read-out of MEF2 transcriptional activity and is onlyof the extreme hypertrophy of individual cardiomyocytes
in HDAC9 mutant mice (Figure 6A, lower image). HDAC9/ basally active in the postnatal heart (Naya et al., 1999).
In the absence of calcineurin signaling, the MEF2-mice showed an enhanced cardiac growth response to
calcineurin that was intermediate between that of wild- dependent reporter was expressed at low levels in both
wild-type and HDAC9 mutant hearts. In contrast, MEF2type and HDAC9/ littermates (Figure 6B). The en-
hanced hypertrophy of HDAC9/ hearts was mirrored activity was elevated in the hearts of -MHC-calcineurin
transgenic mice, and in the HDAC9 mutant, MEF2-LacZby changes in fetal cardiac gene expression, as Northern
blot analysis showed that transcripts for ANF, brain na- expression was activated to even higher levels in re-
sponse to calcineurin signaling (Figure 6D). These find-triuretic peptide (BNP), and -MHC were super-induced
by calcineurin in the absence of HDAC9 (Figure 6C). ings demonstrate that MEF2 responds to signals for
pathologic, but not physiologic hypertrophy and thatWe considered the possibility that the exaggerated
response of HDAC9/ hearts to stress signaling might the responsiveness of MEF2 to calcineurin signaling is
negatively regulated by HDAC9 in vivo.reflect subtle structural or functional cardiac abnormali-
ties that are exacerbated by stress. However, echocardi-
ography failed to reveal any abnormalities in cardiac
function in HDAC9 mutant mice up to 8 months of age. Discussion
We also considered whether noncardiac or systemic
abnormalities could contribute to the sensitized pheno- Stress signals stimulate adult cardiomyocytes to un-
dergo hypertrophy, which is associated with the activa-type of HDAC9 mutants, but we observed no abnormali-
ties in lung, vascular system, or skeletal muscle of the tion of a fetal cardiac gene program that results in mal-
adaptive changes in cardiac contractility and calciummutants. Thus, we conclude that the phenotype repre-
sents a cell-autonomous abnormality of cardiac myo- handling. The results of this study show that stress sig-
nals stimulate an HDAC kinase that phosphorylates con-cytes.
served regulatory serine residues in class II HDACs.
Mutant forms of class II HDACs that cannot be phos-The Transcriptional Activity of MEF2 Is
Hypersensitive to Calcineurin Signaling phorylated render cardiac myocytes refractory to hyper-
trophic stimuli, and mice lacking HDAC9 are sensitizedin HDAC9/ Mice
Since MEF2 is activated by stress signals and repressed to stress signals that induce hypertrophy. A model con-
sistent with these findings is shown in Figure 7.by class II HDACs, we used a line of transgenic mice,
Cell
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Activation of an HDAC Kinase
by Hypertrophic Signals
CaMK activity is elevated in failing human hearts (Kirch-
hefer et al., 1999), and constitutively activated CaM ki-
nases can induce cardiac hypertrophy in vivo and in
vitro (Kato et al., 2000; Passier et al., 2000; Zhang et al.,
2002). The ability of CaMK signaling to phosphorylate
the conserved regulatory sites in MITR and class II
HDACs in transfected cells (McKinsey et al., 2000a,
2000b; Zhang et al., 2001b) suggested that CaMK might
be involved in the transduction of hypertrophic stimuli
through HDACs in vivo. Indeed, our results demonstrate
the existence of a protein kinase activity in cardiac ex-
tracts that phosphorylates the CaMK sites in MITR and
class II HDACs and point to this enzyme as an effector
in hypertrophic signaling pathways. However, the kinase
detected in this assay does not appear to correspond
to a typical CaMK, based on its insensitivity to all of the
CaMK inhibitors we tested (KN62, KN93, and AIP), as Figure 7. Repression of Cardiac Hypertrophy by Class II HDACs
well as its failure to bind a calmodulin affinity column Class II HDACs (4, 5, 7, and 9) associate with MEF2 and inhibit
and its activity in the presence of EGTA (data not shown). hypertrophy and the fetal gene program. Stress signals stimulate
The kinase is also not recognized by an anti-CaMKIV an HDAC kinase that phosphorylates (P) HDACs at two conserved
serine residues. HDAC kinase is also stimulated by calcineurin.antibody. Although the kinase was partially inhibited by
When phosphorylated, HDACs bind 14-3-3, dissociate from MEF2,HA1004, which is known to inhibit PKA, PKG, and CaMK,
and are exported from the nucleus. Upon release of HDACs, MEF2this inhibitor may also inhibit other untested or unknown
is free to associate with histone acetyltransferases (HATs) and tokinases. Since other inhibitors for PKA, PKG, and CaMK activate downstream target genes that drive a hypertrophic re-
do not inhibit the HDAC kinase, it does not appear that sponse. MEF2 also interacts with NFAT and GATA transcription
these kinases singly or in combination can account for factors, which have been implicated in hypertrophic gene ex-
pression.the activity. Nevertheless, it is possible that the kinase
is a CaMK-like kinase, since purified CaMK can phos-
phorylate the same sites in HDACs. The identity of this that in order for stress signals to induce hypertrophy,
stress-responsive kinase remains to be determined. the stimuli must exceed a threshold of repressive activity
The stimulation of HDAC kinase activity by stress sig- that represents the combined actions of class II HDACs.
nals in vivo, coupled with the ability of signal-resistant In HDAC9 mutant mice, this threshold is lowered, with
HDAC mutants to block hypertrophy of primary cardio- resulting exacerbation of the hypertrophic response.
myocytes in the presence of diverse agonists in vitro,
This sensitized phenotype also suggests that stress sig-
suggests that this kinase integrates multiple hypertro-
nals do not inactivate all the repressive activity of class
phic signaling pathways. Of course, activation of HDAC
II HDACs and that residual nonphosphorylated HDACskinase activity by different hypertrophic stimuli need
dampen the hypertrophic response. Otherwise, remov-not be direct and could involve secondary pathways or
ing HDAC9 would not be expected to augment the hy-autocrine signaling loops.
pertrophic response.
While HDAC9 mutant mice show an enhanced re-Repression of Cardiac Hypertrophy by MITR
sponse to stress signals, they do not show abnormaland Class II HDACs
cardiac growth during postnatal development when theThe phenotype of HDAC9 mutant mice demonstrates
heart enlarges through physiologic hypertrophy. Thatthat this HDAC acts in the adult heart to suppress the
simply eliminating HDAC activity is insufficient to causefetal gene program and hypertrophic growth. In the ab-
hypertrophy suggests that the hypertrophic programsence of stress, these mice showed normal cardiac size
also requires positive signals that are likely to be di-and function at young age, whereas at old age or when
rected at other targets. (By analogy, releasing the brakestressed by pressure overload or calcineurin activation,
of a car is insufficient to make it move without alsothey showed a severely exaggerated hypertrophic re-
stepping on the accelerator.) It is notable in this regardsponse. Remarkably, deletion of only a single HDAC9
that MEF2 is activated by several stress response path-allele was sufficient to sensitize animals to hypertrophic
ways through mechanisms independent of HDAC dere-stimuli, resulting in a cardiac growth response interme-
pression (McKinsey et al., 2002).diate between that of wild-type and HDAC9/ mice.
The lack of enhanced hypertrophy during postnatalThese findings demonstrate that the hypertrophic pro-
cardiac development in HDAC9 mutant mice also sug-gram is exquisitely sensitive to the repressive influence
gests that the intracellular pathways that transduceof HDAC9 and imply that, under conditions of stress,
pathologic and physiologic signals leading to hypertro-HDACs 4, 5, and 7, which are also expressed in the adult
phy are distinct and that HDAC9 responds specificallyheart, cannot fully compensate for a reduction in HDAC9
to stress signals that activate the fetal gene program.expression.
The selective activation of fetal cardiac genes by stressThe enhanced hypertrophic phenotype of HDAC9 mu-
signals, but not during normal postnatal growth of thetant mice, and the suppression of cardiomyocyte hyper-
trophy by overexpressed HDACs in vitro, also suggest heart, supports the notion that pathologic and physio-
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218–328 of HDAC5, or 180–283 of HDAC9 fused to glutathionelogic hypertrophy depends on different signaling path-
S-transferase (GST). GST-fusion proteins were also made with ser-ways.
ine-to-alanine mutations at positions 246, 259, and 218 in HDACs
4, 5, and 9, respectively. GST-HDAC protein (1g) was conjugated to
Transcriptional Targets for HDACs glutathione-agarose beads. GST-HDAC-bound beads were washed
in the Hypertrophic Pathway with PBS and subsequently incubated with heart protein lysate (100
g) in lysis buffer for 2 hr at 4
C. Beads were washed twice withThe super-activation of MEF2 activity in HDAC9 mutant
the same buffer and equilibrated with kinase reaction buffer (25 mMmice in response to calcineurin signaling indicates that
HEPES [pH 7.6], 10 mM MgCl2, and 0.1 mM CaCl2). Beads were thenMEF2 is a downstream target for repression by HDAC9/
resuspended in kinase reaction buffer (30 l) containing 12.5 MMITR in vivo. However, MEF2 need not be the sole tran-
ATP and 5 Ci [-32P]-ATP and reactions were allowed to proceed
scriptional effector of the stress-response pathways for 30 min at room temperature. Reactions were then boiled, and
governed by HDACs. It should also be pointed out that phosphoproteins were resolved by SDS-PAGE, visualized by autora-
diography, and quantified using a phosphorimager.MEF2 interacts with GATA and NFAT transcription fac-
tors, which also associate with each other (Molkentin
Transgenic Mice and -Galactosidase Staininget al., 1998; Morin et al., 2000; Youn et al., 2000). These
Mice bearing transgenes encoding a constitutively active form offactors have each been shown to be capable of activat-
calcineurin under control of the -MHC promoter, and mice carrying
ing the fetal gene program in response to hypertrophic the desMEF2-LacZ transgene (MEF2 indicator mice) have been de-
signaling (Liang et al., 2001; Molkentin et al., 1998). Thus, scribed (Molkentin et al., 1998; Naya et al., 1999). LacZ gene expres-
HDAC has the potential to repress hypertrophy-respon- sion was determined as described (Naya et al., 1999).
sive genes by being recruited via MEF2 to gene regula-
Cardiomyocyte Cell Culture and Adenovirus Infectionstory regions that do not contain direct binding sites for
Primary rat cardiomyocytes were prepared as described (MolkentinMEF2 (see Figure 7).
et al., 1998). Eighteen hours after plating, cells were infected with
The ability of HDACs to repress cardiac hypertrophy adenovirus for 2 hr and subsequently cultured in serum-free medium
implies that HAT activity is required for hypertrophy and for 24 hr before stimulation for another 24 hr with PE (100 M;
activation of the fetal gene program. Notably, the coacti- Sigma), ET-1 (100 nM; American Peptide Company, Inc), IGF-1 (100
ng/ml; American Peptide Company, Inc), ANGII (100 nM; Americanvators p300 and CBP, which possess HAT activity, have
Peptide Company, Inc), or FBS (2.5%; Sigma).been shown to interact with the same region of MEF2
Myc- and FLAG-tagged derivatives of MITR and HDAC5 and theirthat interacts with class II HDACs and to be activated
signal-resistant counterparts (S218/448A and S259/498A, respec-by the same signals that inactivate class II HDACs (Sar- tively) have been described (McKinsey et al., 2000a; Zhang et al.,
torelli et al., 1997; Impey et al., 2002). The signal-depen- 2001b). For adenovirus production, cDNAs were cloned into the
dent dissociation of phospho-HDACs from MEF2 would pAC-CMV vector and the resultant constructs were cotransfected
into 293 cells with pJM17 using Fugene 6 (Roche). Primary lysatestherefore allow for the association of MEF2 with p300/
were used to reinfect 293 cells and viral plaques were obtainedCBP and consequent activation of stress-response and
using the agar overlay method. Clonal populations of adenovirusesfetal cardiac genes.
were amplified by reinfecting 293 cells and titered.
Therapeutic Implications Immunocytochemistry
Cardiac hypertrophy is associated with an increased Primary cardiomyocytes plated on laminin-coated glass coverslips
risk of morbidity and mortality. Pathologic changes in were fixed and stained as described (Zhang et al., 2001b). Fluores-
cent images were collected on a LSM 410 Zeiss confocal micro-the hypertrophic heart have been correlated with altered
scope and were processed with Adobe Photoshop. The followingcontractility that results from activation of the fetal car-
primary and secondary antibodies were used at 1:200 dilution: anti-diac gene program (Lowes et al., 2002). The realization
-actinin (EA-53; Sigma), anti-Myc (9E10 and A-14; Santa Cruz),
that HDACs act as repressors of the hypertrophic pro- anti-rat-ANF (IHC9103; Peninsula Laboratories, Inc.), Texas Red-
gram and stress-responsive substrates for an HDAC conjugated anti-mouse or anti-rabbit IgG (Vector Labs), and fluores-
kinase suggests that therapeutic strategies to inhibit cein-conjugated anti-mouse or anti-rabbit IgG (Vector Labs).
this kinase could be beneficial in the treatment of cardiac
RNA Isolation and Analysishypertrophy. Current strategies for treatment of hyper-
Total RNA was purified from cultured cells or intact hearts withtrophy and heart failure target early steps in hypertro-
Trizol reagent (Invitrogen) according to manufacturer’s instructions.
phic signaling pathways, such as cell surface receptors, Northern and RNA dot blot analyses were performed with 20 g
calcium channels and handling proteins, and compo- and 2 g, respectively, of total RNA. For RT-PCR, total RNA was
nents of the -adrenergic receptor system. Given the used as a template for reverse transcriptase and random hexamer
primers (Invitrogen). Sequences of oligonucleotide probes and prim-plethora of signals that cause hypertrophy and heart
ers are available upon request.failure, an alternative approach would be to target an
effector common to many such pathways. Class II
Chromatin Immunoprecipitation (ChIP) Assay
HDACs and their regulatory kinase(s) appear to repre- ChIP assays were performed as described (Lu et al., 2000b), using
sent such a point of convergence and as such represent soluble chromatin prepared from cardiomyocytes. Equal amounts
potential therapeutic targets. of chromatin from each sample (normalized by ethidium bromide
staining of DNA) were immunoprecipitated with an anti-acetylated
Experimental Procedures histone H3 antibody (Upstate Biotechnology). Ten percent of the
precipitated DNA was subjected to 28 cycles of PCR in the presence
of [32P]-dCTP with primers specific for the ANF, -MHC, -cardiacHDAC Kinase Assays
Adult mouse hearts were homogenized in 1 ml of lysis buffer (PBS actin, or GAPDH promoters. As a control for DNA content, PCR
reactions were also performed on chromatin samples prior to immu-containing 1 mM EDTA, 0.1% Triton X-100, 1 mM PMSF, and prote-
ase inhibitor cocktail [Roche]). After brief sonication, lysates were noprecipitation. Twenty percent of each reaction mixture was re-
solved through a 5% native polyacrylamide gel, visualized, andclarified by ultra-centrifugation, and protein concentration was de-
termined. quantified using a phosphorimager (Molecular Dynamics). Primer
sequences are available upon request.GST-HDAC substrates contained amino acids 208–310 of HDAC4,
Cell
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Generation of HDAC9 Targeting Construct and Mutant Mice Liang, Q., De Windt, L.J., Witt, S.A., Kimball, T.R., Markham, B.E.,
and Molkentin, J.D. (2001). The transcription factors GATA4 andThe HDAC9 targeting construct was generated using the pN-Z-TK2
GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J.vector, which contains a nuclear LacZ (nLacZ) cassette and a neo-
Biol. Chem. 276, 30245–30253.mycin-resistance gene (kindly provided by R. Palmiter). Following
electroporation into the R1 ES cell line and positive-negative selec- Lowes, B.D., Gilbert, E.M., Abraham, W.T., Minobe, W.A., Larrabee,
tion, 780 individual ES cell clones were isolated and analyzed by P., Ferguson, D., Wolfel, E.E., Lindenfeld, J., Tsvetkova, T., Robert-
Southern blotting for homologous recombination. Four clones with son, A.D., et al. (2002). Myocardial gene expression in dilated cardio-
a disrupted HDAC9 gene were injected into 3.5-day mouse C57BL/6 myopathy treated with beta-blocking agents. N. Engl. J. Med. 346,
blastocysts, and the resulting chimeric male mice were bred to 1357–1365.
C57BL/6 females to achieve germline transmission of the mutant Lu, J., McKinsey, T.A., Nicol, R.L., and Olson, E.N. (2000a). Signal-
allele. dependent activation of the MEF2 transcription factor by dissocia-
tion from histone deacetylases. Proc. Natl. Acad. Sci. USA 97, 4070–
Thoracic Aorta Banding 4075.
Six-to-eight-week-old male wild-type and HDAC9/ littermates un- Lu, J., McKinsey, T.A., Zhang, C.L., and Olson, E.N. (2000b). Regula-
derwent either a sham operation or were subjected to pressure tion of skeletal myogenesis by association of the MEF2 transcription
overload induced by thoracic aorta banding as described (Hill et factor with class II histone deacetylases. Mol. Cell 6, 233–244.
al., 2000).
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